Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
1.020
+0.031 (3.18%)
Nov 22, 2024, 4:00 PM EST - Market closed
Rallybio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 19.25 | 25.39 | 27.2 | 18.74 | 7.67 | 6.28 |
| Research & Development | 53.54 | 53.54 | 40.69 | 26.91 | 17.63 | 11.37 |
| Operating Expenses | 72.8 | 78.93 | 67.88 | 45.65 | 25.3 | 17.64 |
| Operating Income | -66.7 | -78.93 | -67.88 | -45.65 | -25.3 | -17.64 |
| Interest Expense | - | - | - | -0.01 | -0.05 | -0.04 |
| Interest & Investment Income | 4.85 | 6.15 | 1.96 | 0.05 | 0.17 | 0.2 |
| Earnings From Equity Investments | -2.42 | -2.04 | -1.08 | -1.51 | -1.52 | -0.1 |
| Other Non Operating Income (Expenses) | 0.6 | 0.26 | 0.34 | 0.1 | 0.24 | 0.02 |
| Pretax Income | -66.97 | -74.56 | -66.65 | -47.01 | -26.46 | -17.56 |
| Income Tax Expense | - | - | - | - | -0.02 | - |
| Net Income | -66.97 | -74.56 | -66.65 | -47.01 | -26.45 | -17.56 |
| Net Income to Common | -66.97 | -74.56 | -66.65 | -47.01 | -26.45 | -17.56 |
| Shares Outstanding (Basic) | 43 | 40 | 32 | 26 | 17 | 2 |
| Shares Outstanding (Diluted) | 43 | 40 | 32 | 26 | 17 | 2 |
| Shares Change (YoY) | 8.55% | 27.11% | 24.70% | 46.76% | 913.79% | - |
| EPS (Basic) | -1.57 | -1.84 | -2.09 | -1.84 | -1.52 | -10.24 |
| EPS (Diluted) | -1.57 | -1.84 | -2.09 | -1.84 | -1.52 | -10.24 |
| Free Cash Flow | -51.08 | -60.28 | -57.34 | -45.87 | -22.18 | -15.21 |
| Free Cash Flow Per Share | -1.20 | -1.49 | -1.80 | -1.80 | -1.28 | -8.87 |
| EBITDA | -66.56 | -78.78 | -67.72 | -45.54 | -25.24 | -17.62 |
| D&A For EBITDA | 0.14 | 0.15 | 0.17 | 0.11 | 0.06 | 0.03 |
| EBIT | -66.7 | -78.93 | -67.88 | -45.65 | -25.3 | -17.64 |
Source: S&P Capital IQ. Standard template.
Financial Sources.